Immunic
IMUX
IMUX
55 hedge funds and large institutions have $35M invested in Immunic in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.67% more ownership
Funds ownership: 0% → 0.67% (+0.67%)
32% less capital invested
Capital invested by funds: $51.5M → $35M (-$16.6M)
Holders
55
Holding in Top 10
–
Calls
$219K
Puts
$100K
Top Buyers
| 1 | +$823K | |
| 2 | +$277K | |
| 3 | +$270K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$217K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$210K |
Top Sellers
| 1 | -$1.42M | |
| 2 | -$184K | |
| 3 | -$136K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$81K |
| 5 |
Goldman Sachs
New York
|
-$73.7K |